Most neurologists today recognize functional neurological disorder (FND) as a genuine, complex condition, not a diagnosis of exclusion or a polite way of saying “it’s all in your head.” But that doesn’t mean every neurologist feels confident treating it, and many patients still sense skepticism in the exam room. The gap between what the field officially endorses and what individual doctors communicate to patients remains one of the most frustrating aspects of living with functional symptoms.
FND Is One of the Most Common Neurology Diagnoses
Functional symptoms are far from rare in neurology clinics. A study of 884 new outpatients in Australia found that 15% received an FND diagnosis, making it the third most common reason for a neurology referral. A similar study of 577 new patients in Aberdeen, UK, also landed at 15%, where FND was the second most common diagnosis after headache and migraine. Across studies, anywhere from 6% to 16% of new neurology patients have a functional disorder, depending on how broadly the term is defined.
That prevalence matters because it means neurologists encounter FND constantly. This isn’t some obscure condition a neurologist might see once in a career. It’s part of their daily caseload, which creates pressure on the field to take it seriously and develop better approaches.
How Professional Attitudes Have Shifted
A global survey of neurologists and psychiatrists revealed that 61% now view functional seizures (one of the most common forms of FND) as caused by both psychological and biological factors, not purely one or the other. This reflects a broader shift toward what’s called a biopsychosocial model: the idea that FND arises from a combination of how the brain processes signals, psychological stressors, and social context. The old assumption that functional symptoms require an identifiable psychological trauma has been formally dropped from diagnostic criteria.
That said, the survey also found that nearly 58% of respondents considered functional seizures harder to treat than epilepsy. This is a telling detail. Neurologists aren’t dismissing FND as trivial. Many see it as genuinely difficult, which can translate into different reactions depending on the doctor. Some become more invested in finding solutions. Others feel out of their depth and may refer patients elsewhere quickly, sometimes leaving patients feeling brushed off.
The preferred first-line treatment among surveyed neurologists and psychiatrists was psychotherapy, endorsed by about 80% of respondents. This doesn’t mean they think the problem is purely psychological. It reflects the reality that specialized physical rehabilitation and psychological approaches currently have the strongest evidence base, while there’s no equivalent of an anti-seizure medication that reliably works for functional symptoms.
Diagnosis Is Now Based on Positive Signs, Not Ruling Everything Else Out
One of the biggest changes in recent years is how FND gets diagnosed. The older approach treated it as a leftover diagnosis: if scans and blood work came back normal, the assumption was the problem must be functional. This left patients feeling like they were only told what they didn’t have, never what they did have.
Current diagnostic criteria, updated in the DSM-5, flipped this approach. Neurologists now use specific physical exam findings that positively identify FND rather than simply excluding other conditions. Researchers have catalogued at least 46 clinical signs for functional weakness, sensory changes, and movement disorders. For functional weakness, one well-known example involves testing whether a leg that appears paralyzed on direct testing actually activates normally during an opposite-leg movement. For functional tremor, a neurologist might ask you to tap a rhythm with your unaffected hand and observe whether the tremor changes its frequency to match, something that doesn’t happen with tremors caused by conditions like Parkinson’s disease.
This shift matters enormously for patients. A neurologist who uses positive signs can explain exactly what they found on exam and why it points to FND, rather than shrugging and saying they couldn’t find anything wrong. The diagnosis becomes something concrete, with physical evidence behind it.
Misdiagnosis Rates Are Lower Than Many Patients Fear
A common worry among people diagnosed with FND is that something else, something “organic,” is being missed. This fear isn’t irrational, especially given the condition’s complicated history. But long-term follow-up data is reassuring. One large study tracking over 2,300 patients found that only 2% were later rediagnosed with a different neurological condition. Primary care studies with repeated diagnostic assessments after thorough initial workups found misdiagnosis rates as low as 0.5%.
A smaller, more intensive re-evaluation study did find a higher rate of 12%, but this involved actively re-investigating patients who had ongoing symptoms, a scenario where clinicians are specifically looking for anything that might have been missed. The takeaway is that when a neurologist uses positive diagnostic signs (rather than simply running out of other ideas), the diagnosis is reliable. It’s comparable in accuracy to many other neurological diagnoses.
A Major Gap in Training
Here’s where the disconnect between the field’s official stance and individual patient experiences becomes clearer. Despite FND being one of the most common conditions neurologists see, formal education on it during medical training is minimal. A review published in the journal Neurology noted a “large gap in neurology education regarding FND, with little to no formal teaching over the course of medical education.” Many practicing neurologists report they don’t feel they have strong knowledge of the condition.
This training gap has real consequences. A neurologist who hasn’t been taught how to explain FND effectively may deliver the diagnosis poorly, leaving patients confused or feeling dismissed. They may lack confidence in the positive diagnostic signs and fall back on the outdated “we can’t find anything” framing. They may not know what treatments to recommend or where to refer patients. The result is that patients often interpret their neurologist’s discomfort as disbelief, when in many cases it’s actually uncertainty about what to do next.
The Funding Problem
FND’s standing in neurology is also shaped by a stark imbalance between its clinical burden and the research dollars it receives. Hospital and emergency department charges for adult and pediatric FND reached $2 billion in 2019, a 49% increase from just two years earlier. Adult inpatient charges alone hit $1.6 billion, higher than charges for neuroinflammatory diseases, refractory epilepsy, or motor neuron diseases. Emergency department charges for adult FND rose 67% in two years.
Despite these numbers, FND receives less research funding relative to its healthcare costs than any of those comparison conditions. This underfunding means fewer clinical trials, fewer trained specialists, and fewer treatment centers. For patients, it translates into long wait times for specialists who actually understand the condition and limited treatment options in many regions.
What Patients Actually Experience in the Exam Room
The honest picture is mixed. The neurology field has moved substantially toward recognizing FND as a legitimate, diagnosable, treatable brain condition. The biopsychosocial model is widely accepted. Positive diagnostic signs are well established. Major neurology journals publish FND research regularly. Professional organizations have issued consensus statements supporting it as a real disorder.
But individual neurologists vary widely. Some have deep expertise and can explain the diagnosis with clarity and compassion. Others have had almost no training in FND and may still carry outdated assumptions, consciously or not, that functional symptoms are less “real” or less deserving of their time than conditions visible on an MRI. The terminology itself is still evolving: many neurologists still prefer the term “psychogenic” over “functional,” which can inadvertently signal to patients that the doctor thinks it’s a psychological problem rather than a neurological one.
If your neurologist diagnosed you with FND but didn’t explain what positive signs they found, didn’t outline a treatment plan, or left you feeling like they were simply ruling out “the serious stuff,” that likely reflects a training gap rather than the current scientific consensus. Seeking out a neurologist or rehabilitation team with specific FND experience can make a significant difference in both the quality of explanation you receive and the treatment options available to you.